Search

everythinglearnresearchcommunity

for

Search:↓

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Certain drugs that block specific enzymes can help treat prostate diseases.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cow milk sugars increase fat production and inflammation in skin oil cells.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.